The FDA's approach to dietary supplements is fundamentally different from its regulation of pharmaceutical drugs. While many people assume supplements undergo the same rigorous pre-market testing and approval as medications, the reality is more nuanced. The FDA classifies supplements as a category of food products and uses a compliance-and-enforcement model rather than requiring manufacturers to prove safety and efficacy before products reach shelves. This framework, established by the Dietary Supplement Health and Education Act (DSHEA) in 1994, means supplement companies bear significant responsibility for ensuring their products are safe and truthfully labeled—but the burden of proof for removing an unsafe product often falls on the FDA rather than the manufacturer. Understanding how the FDA actually regulates supplements will help you evaluate product claims more critically and identify trustworthy sources.

How the FDA Defines and Classifies Supplements

The FDA categorizes dietary supplements as foods, not drugs, even though they may contain vitamins, minerals, amino acids, herbs, and other bioactive compounds. This distinction matters because it determines the regulatory pathway. Under DSHEA, a dietary supplement is defined as a product intended to supplement the diet by increasing total dietary intake of a nutrient. It can be a vitamin, mineral, amino acid, herb, botanical, or a concentrate, metabolite, constituent, or extract of these substances.

What supplements cannot legally do is claim to diagnose, cure, mitigate, treat, or prevent any disease. This is the line that separates a supplement from a drug in the eyes of the FDA. For example, a zinc supplement can claim to